Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders Cannabis Investing News
Lobe Sciences Commences Trading Under New Name and Announces Rebranding and Corporate Update Cannabis Investing News
MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities Psychedelics Investing
